CAR T-cell Infusion Following Checkpoint Inhibition Can Induce Remission in Chemorefractory Post-transplant Lymphoproliferative Disorder of the CNS.

Autor: Rösler W; Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland., Bink A; Department of Neuroradiology, University Hospital Zurich, Switzerland., Bissig M; Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland., Imbach L; Department of Neurology, University Hospital Zurich, Switzerland., Marques Maggio E; Institute of Pathology and Molecular Pathology, University Hospital Zurich, Switzerland., Manz MG; Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland., Müller T; Department of Nephrology, University Hospital Zurich, Switzerland., Roth P; Department of Neurology, University Hospital Zurich, Switzerland., Rushing E; Institute of Neuropathology, University Hospital Zurich, Switzerland., Widmer C; Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland., Zenz T; Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland., von Moos S; Department of Nephrology, University Hospital Zurich, Switzerland., Müller AMS; Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland.; Department of Blood Group Serology and Transfusion Medicine, University Hospital Vienna, Austria.
Jazyk: angličtina
Zdroj: HemaSphere [Hemasphere] 2022 Jun 17; Vol. 6 (7), pp. e733. Date of Electronic Publication: 2022 Jun 17 (Print Publication: 2022).
DOI: 10.1097/HS9.0000000000000733
Databáze: MEDLINE